These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 25182141

  • 1. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis.
    Kalantari S, Nafar M, Rutishauser D, Samavat S, Rezaei-Tavirani M, Yang H, Zubarev RA.
    BMC Nephrol; 2014 Sep 02; 15():141. PubMed ID: 25182141
    [Abstract] [Full Text] [Related]

  • 2. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
    Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
    BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
    [Abstract] [Full Text] [Related]

  • 3. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
    Tong J, Jin Y, Weng Q, Yu S, Jafar Hussain HM, Ren H, Xu J, Zhang W, Li X, Wang W, Xie J, Chen N.
    Am J Nephrol; 2020 Feb 03; 51(6):442-452. PubMed ID: 32348995
    [Abstract] [Full Text] [Related]

  • 4. Comparative proteomic analysis of children FSGS FFPE tissues.
    Ni J, Tian S, Bai L, Lv Q, Liu J, Liu J, Fang Y, Zhai Y, Shen Q, Rao J, Ding C, Xu H.
    BMC Pediatr; 2022 Dec 12; 22(1):707. PubMed ID: 36503536
    [Abstract] [Full Text] [Related]

  • 5. THE METABOLOMICS SIGNATURE ASSOCIATED WITH RESPONSIVENESS TO STEROID THERAPY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS: A PILOT STUDY.
    Chashmniam S, Kalantari S, Nafar M, Boroumandnia N.
    Rev Invest Clin; 2019 Dec 12; 71(2):106-115. PubMed ID: 31056594
    [Abstract] [Full Text] [Related]

  • 6. [Study of urinary markers of different podocytopathies by proteomic analysis].
    Vinogradov AA, Chebotareva NV, Bugrova AE, Brzhozovskiy AG, Krasnova TN, Nasibullina KZ, Kononikhin AS, Moiseev SV.
    Ter Arkh; 2023 Aug 17; 95(6):457-461. PubMed ID: 38158963
    [Abstract] [Full Text] [Related]

  • 7. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis.
    Shui HA, Huang TH, Ka SM, Chen PH, Lin YF, Chen A.
    Nephrol Dial Transplant; 2008 Jan 17; 23(1):176-85. PubMed ID: 17881425
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
    Trachtman H, Vento S, Herreshoff E, Radeva M, Gassman J, Stein DT, Savin VJ, Sharma M, Reiser J, Wei C, Somers M, Srivastava T, Gipson DS.
    BMC Nephrol; 2015 Jul 22; 16():111. PubMed ID: 26198842
    [Abstract] [Full Text] [Related]

  • 9. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K, Warner E, Bollinger C, Wright D, Fitch RM.
    BMC Nephrol; 2020 Jun 15; 21(1):226. PubMed ID: 32539845
    [Abstract] [Full Text] [Related]

  • 10. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
    Chebotareva NV, Vinogradov A, Brzhozovskiy AG, Kashirina DN, Indeykina MI, Bugrova AE, Lebedeva M, Moiseev S, Nikolaev EN, Kononikhin AS.
    Int J Mol Sci; 2022 Oct 20; 23(20):. PubMed ID: 36293475
    [Abstract] [Full Text] [Related]

  • 11. Distinct urinary lipid profile in children with focal segmental glomerulosclerosis.
    Erkan E, Zhao X, Setchell K, Devarajan P.
    Pediatr Nephrol; 2016 Apr 20; 31(4):581-8. PubMed ID: 26537928
    [Abstract] [Full Text] [Related]

  • 12. Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis.
    Youssef DM, El-Shal AA.
    Iran J Kidney Dis; 2012 Sep 20; 6(5):355-60. PubMed ID: 22976261
    [Abstract] [Full Text] [Related]

  • 13. A form of apolipoprotein a-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation.
    Lopez-Hellin J, Cantarell C, Jimeno L, Sanchez-Fructuoso A, Puig-Gay N, Guirado L, Vilariño N, Gonzalez-Roncero FM, Mazuecos A, Lauzurica R, Burgos D, Plumed JS, Jacobs-Cacha C, Jimenez C, Fernandez A, Fernandez-Alvarez P, Torregrosa V, Nieto JL, Meseguer A, Alonso A, GREAT Study Group.
    Am J Transplant; 2013 Feb 20; 13(2):493-500. PubMed ID: 23205849
    [Abstract] [Full Text] [Related]

  • 14. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
    An JN, Hyeon JS, Jung Y, Choi YW, Kim JH, Yang SH, Oh S, Kwon S, Lee SH, Cho JH, Park SH, Ha H, Kim DK, Lee JP, Hwang GS.
    Sci Rep; 2019 Oct 11; 9(1):14707. PubMed ID: 31605028
    [Abstract] [Full Text] [Related]

  • 15. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
    Pediatr Nephrol; 2017 Oct 11; 32(10):1897-1905. PubMed ID: 28540445
    [Abstract] [Full Text] [Related]

  • 16. Proteomic profile‑based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome.
    Wang Y, Zheng C, Wang X, Zuo K, Liu Z.
    Mol Med Rep; 2017 Nov 11; 16(5):6276-6284. PubMed ID: 28849145
    [Abstract] [Full Text] [Related]

  • 17. NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis.
    Monteiro EJ, Pereira AC, Pereira AB, Krieger JE, Mastroianni-Kirsztajn G.
    J Nephrol; 2006 Nov 11; 19(3):366-71. PubMed ID: 16874699
    [Abstract] [Full Text] [Related]

  • 18. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
    Woroniecki RP, Shatat IF, Supe K, Du Z, Kaskel FJ.
    Am J Nephrol; 2008 Nov 11; 28(1):83-90. PubMed ID: 17914249
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 11; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 20. Clinical Significance of Urinary Biomarkers in Patients With Primary Focal Segmental Glomerulosclerosis.
    Zhang Q, Jiang C, Tang T, Wang H, Xia Y, Shao Q, Zhang M.
    Am J Med Sci; 2018 Apr 11; 355(4):314-321. PubMed ID: 29661344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.